Print

V526-001 MRKAd5 and MRKAd6 HIV-1 Trigene Vaccines

Safety and Immunogenicity of the MRKAd5 and MRKAd6 HIV-1 Trigene Vaccines Alone and in Combination in Healthy Adults

Trial Details:

I Completed
Merck May 01, 2005
MRKAd5 HIV-1 gag/pol/nef,MRKAd5+6 HIV-1,MRKAd6 Ad5 Gag,pol,nef; Ad5 & Ad6 Nef, gag, pol B; Ad6 Gag,pol,nef B
MRKAd5 HIV-1 gag/pol/nef Viral Vector - Adeno
MRKAd6 Viral Vector - Adeno
MRKAd5+6 HIV-1 Viral Vector - Adeno
USA 146
NCT00850616
http://clinicaltrials.gov/ct2/show/NCT00850616